Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DREAM-CKD: Desidustat Safety in Anemia of CKD
NCT05515367Phase 4Recruiting
- Sponsor
- Zydus Lifesciences Limited
- Start
- Apr 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of desidustat in anemia of chronic kidney disease (CKD-A), sponsored by Zydus Lifesciences Limited. Started Apr 2023; status: recruiting.
02
Drugs
desidustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT05515367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05515367.